Satoshi. Kashiwagi, et.al., eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity., Biochemical and biophysical research communications, 2013, 431

http://rdf.ncbi.nlm.nih.gov/pubmed/23291238

Satoshi. Kashiwagi, et.al., eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity., Biochemical and biophysical research communications, 2013, 431

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Nos3<tm2.1Plh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5499171
• Nos3<tm3.1Plh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5499172

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased brown adipose tissue amount_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0000005I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased circulating LDL cholesterol level_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0000182I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased circulating free fatty acid level_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0001554I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased circulating insulin level_Nos3<tm3.1Plh>/Nos3<tm3.1Plh>
  http://metadb.riken.jp/0002079I129S4SvJaeC57BL6Nos3tm31PlhNos3tm31PlhNos3tm31Plh
• decreased circulating insulin level_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0002727I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased liver weight_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0002981I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
他12件を見る
• increased mean systemic arterial blood pressure_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0004875I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• decreased adiponectin level_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0004893I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• improved glucose tolerance_Nos3<tm3.1Plh>/Nos3<tm3.1Plh>
  http://metadb.riken.jp/0005292I129S4SvJaeC57BL6Nos3tm31PlhNos3tm31PlhNos3tm31Plh
• insulin resistance_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0005331I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased susceptibility to weight gain_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0005455I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased circulating glucose level_Nos3<tm3.1Plh>/Nos3<tm3.1Plh>
  http://metadb.riken.jp/0005559I129S4SvJaeC57BL6Nos3tm31PlhNos3tm31PlhNos3tm31Plh
• decreased vasodilation_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0005591I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased circulating leptin level_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0005669I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased white fat cell size_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0009118I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• decreased white fat cell size_Nos3<tm3.1Plh>/Nos3<tm3.1Plh>
  http://metadb.riken.jp/0009133I129S4SvJaeC57BL6Nos3tm31PlhNos3tm31PlhNos3tm31Plh
• increased inguinal fat pad weight_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0009292I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh
• increased retroperitoneal fat pad weight_Nos3<tm2.1Plh>/Nos3<tm2.1Plh>
  http://metadb.riken.jp/0009304I129S4SvJaeC57BL6Nos3tm21PlhNos3tm21PlhNos3tm21Plh

class

http://purl.org/net/cito/citesAsAuthority

• Nos3<tm2.1Plh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5499171
• Nos3<tm3.1Plh>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5499172